Hi Stzenit,
City of hope identified cs1 bisantrene & cs2 brenquinar as FTO inhibitors. We’ve only talked on this thread about cs1, since you don’t mind offering alternate views, I’d be interested in your thoughts on cs2 as a competitor to bisantrene...
Note - I too am a firm believer of RAC and am confident we’ll get acquired in the next couple of years.
RAC - Charts & Price Action, page-1458
-
- There are more pages in this discussion • 19,926 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.99 |
Change
-0.020(1.00%) |
Mkt cap ! $337.1M | |||
| Open | High | Low | Value | Volume |
| $2.04 | $2.09 | $1.92 | $540.2K | 267.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1100 | $1.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.99 | 849 | 1 |
View Market Depth
| Last trade - 14.19pm 19/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |